IFNG and neoplasm: One phase II trial assessed the use of injecting Mo-DCs loaded with tumour lysate and matured by TNFα, Poly I:C, and IFNγ in 15 patients with surgically amenable liver metastasis of colon adenocarcinoma that underwent neoadjuvant chemotherapy, surgery and adjuvant chemotherapy.